Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a late-stage study
Related posts
-
Russia declares a ceasefire in Ukraine on May 8-10 for WWII Victory Day
Russia's President Vladimir Putin on Monday declared a three-day ceasefire in Ukraine on May 8-10 to... -
Report: One victim, suspect at large after shooting on Illinois State University campus
Illinois State University officials are reporting one person was injured and a suspect remained at large... -
Trump inauguration got millions from Illinois residents and companies, report shows
More than $5 million of the record-setting $239 million donated to fund President Donald Trump and...